Viatris Inc. (NASDAQ:VTRS) J.P. Morgan 42nd Annual Healthcare Conference January 10, 2024 1:30 PM ET Company Participants Scott A. Smith - CEO Rajiv Malik - President Sanjeev Narula - CFO Conference Call Participants Chris Schott - J.P. Morgan Chris Schott Good morning, everybody. I'm Chris Schott at J.P. Morgan. And it's my pleasure to be hosting a fireside chat today with Viatris. From the company, we're going to have a quick presentation from CEO, Scott Smith and we're going to open up to a Q&A session w ...

1 This document contains proprietary information of Viatris Inc. Unauthorized use, duplication, dissemination or disclosure to third parties is strictly prohibited. © 2023 Viatris Inc. All Rights Reserved. VIATRIS and the Viatris Logo are trademarks of Mylan Inc., a Viatris company. Q3 2023 Earnings November 7, 2023 Forward Looking Statements This presentation contains "forward-looking statements". These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform A ...

Viatris Inc. (NASDAQ:VTRS) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants William Szablewski - Head of Global Capital Markets Scott Smith - Chief Executive Officer Rajiv Malik - President Sanjeev Narula - Chief Financial Officer Brian Roman - Global General Counsel Conference Call Participants Christopher Schott - JPMorgan Nathan Rich - Goldman Sachs Umer Raffat - Evercore ISI Glenn Santangelo - Jefferies Jason Gerberry - Bank of America Ash Verma - UBS David Amsellem - Pi ...

Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the transition period from _____________to___________ Commission file number 001-39695 VIATRIS INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incor ...

Viatris Inc. (NASDAQ:VTRS) Q2 2023 Earnings Call Transcript August 7, 2023 8:30 AM ET Company Participants William Szablewski - Head of Global Capital Markets Scott Smith - Chief Executive Officer Rajiv Malik - President Sanjeev Narula - Chief Financial Officer Jeff Nau - Eye Care Division Conference Call Participants Glenn Santangelo - Jefferies Jason Gerberry - Bank of America Ash Verma - UBS David Amsellem - Piper Sandler Umer Raffat - Evercore ISI Nathan Rich - Goldman Sachs Operator Good morning. My na ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________to___________ Commission file number 001-39695 VIATRIS INC. (724) 514-1800 (Exact name of registrant as specified in its charter) (State or other jurisdictio ...

Viatris Inc. (NASDAQ:VTRS) Q1 2023 Results Conference Call May 8, 2023 8:30 AM ET Company Participants Bill Szablewski - Head of Capital Markets Scott Smith - Incoming Chief Executive Officer Rajiv Malik - President Sanjeev Narula - Chief Financial Officer Conference Call Participants Glenn Santangelo - Jefferies Chris Schott - JPMorgan Balaji Prasad - Barclays David Amsellem - Piper Sandler Ash Verma - UBS Umer Raffat - Evercore ISI Nathan Rich - Goldman Sachs Group Operator Good morning. My name is Gretch ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________to___________ Commission file number 001-39695 VIATRIS INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorpora ...

Viatris Inc. (NASDAQ:VTRS) Q4 2022 Earnings Conference Call February 27, 2023 8:30 AM ET Company Participants Robert Coury - Executive Chairman Scott Smith - Incoming Chief Executive Officer Michael Goettler - Chief Executive Officer Rajiv Malik - President Sanjeev Narula - Chief Financial Officer Jeff Nau - President, Eye Care Division Conference Call Participants Chris Schott - JPMorgan Glenn Santangelo - Jefferies Balaji Prasad - Barclays Jason Gerberry - Bank of America Elliot Wilbur - Raymond James Ash ...

1 This document contains proprietary information of Viatris Inc. Unauthorized use, duplication, dissemination or disclosure to third parties is strictly prohibited. © 2023 Viatris Inc. All Rights Reserved. VIATRIS and the Viatris Logo are trademarks of Mylan Inc., a Viatris company. Q4 and Full Year 2022 Earnings Presentation February 27, 2023 Forward Looking Statements This presentation contains "forward-looking statements". These statements are made pursuant to the safe harbor provisions of the Private Se ...